315.jpeg)
The malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant, has now been recommended for use by the World Health Organization’s Strategic Advisory Group of Experts and the Malaria Policy Advisory Group, paving the way for a global roll-out soon.
Editor In Chief : Dr Dhimant Purohit
Know your world in 60 words - Read News in just 1 minute
Hot Topics
Select the content to hear the Audio
